CACNA2D1: Difference between revisions

Jump to navigation Jump to search
m (Bot: HTTP→HTTPS)
imported>OAbot
m (Open access bot: add pmc identifier to citation with #oabot.)
 
Line 9: Line 9:


==Gabapentinoids==
==Gabapentinoids==
alpha2/delta proteins are believed to be the molecular target of the [[gabapentinoid]]s [[gabapentin]] and [[pregabalin]], which are used to treat [[epilepsy]] and [[neuropathic pain]].<ref>{{cite journal | vauthors =Rogawski MA, Bazil CW | title = New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels | journal = Curr Neurol Neurosci Rep | date = July 2008 | volume = 8 | issue = 4 | pages = 345–52 | pmid = 18590620 | doi=10.1007/s11910-008-0053-7 | pmc=2587091}}</ref>
alpha2/delta proteins are believed to be the molecular target of the [[gabapentinoid]]s [[gabapentin]] and [[pregabalin]], which are used to treat [[epilepsy]] and [[neuropathic pain]].<ref>{{cite journal | vauthors =Rogawski MA, Bazil CW | title = New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels | journal = Curr Neurol Neurosci Rep | date = July 2008 | volume = 8 | issue = 4 | pages = 345–52 | pmid = 18590620 | doi=10.1007/s11910-008-0053-7 | pmc=2587091}}</ref><ref>{{Cite journal|last=Patel|first=Ryan|last2=Dickenson|first2=Anthony H.|date=2016-04-01|title=Mechanisms of the gabapentinoids andα2δ-1 calcium channel subunit in neuropathic pain|url=http://doi.wiley.com/10.1002/prp2.205|journal=Pharmacology Research & Perspectives|language=en|volume=4|issue=2|doi=10.1002/prp2.205|issn=2052-1707}}</ref><ref>{{Cite journal|last=Patel|first=Ryan|last2=Bauer|first2=Claudia S.|last3=Nieto-Rostro|first3=Manuela|last4=Margas|first4=Wojciech|last5=Ferron|first5=Laurent|last6=Chaggar|first6=Kanchan|last7=Crews|first7=Kasumi|last8=Ramirez|first8=Juan D.|last9=Bennett|first9=David L. H.|date=2013-10-16|title=α2δ-1 Gene Deletion Affects Somatosensory Neuron Function and Delays Mechanical Hypersensitivity in Response to Peripheral Nerve Damage|url=http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.1026-13.2013|journal=Journal of Neuroscience|volume=33|issue=42|pages=16412–16426|doi=10.1523/jneurosci.1026-13.2013|pmc=3797367}}</ref>


==See also==
==See also==

Latest revision as of 19:11, 15 May 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Voltage-dependent calcium channel subunit alpha-2/delta-1 is a protein that in humans is encoded by the CACNA2D1 gene.[1][2]

This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized.[2]

Gabapentinoids

alpha2/delta proteins are believed to be the molecular target of the gabapentinoids gabapentin and pregabalin, which are used to treat epilepsy and neuropathic pain.[3][4][5]

See also

References

  1. Powers PA, Scherer SW, Tsui LC, Gregg RG, Hogan K (Jun 1994). "Localization of the gene encoding the alpha 2/delta subunit (CACNL2A) of the human skeletal muscle voltage-dependent Ca2+ channel to chromosome 7q21-q22 by somatic cell hybrid analysis". Genomics. 19 (1): 192–3. doi:10.1006/geno.1994.1044. PMID 8188232.
  2. 2.0 2.1 "Entrez Gene: CACNA2D1 calcium channel, voltage-dependent, alpha 2/delta subunit 1".
  3. Rogawski MA, Bazil CW (July 2008). "New molecular targets for antiepileptic drugs: alpha(2)delta, SV2A, and K(v)7/KCNQ/M potassium channels". Curr Neurol Neurosci Rep. 8 (4): 345–52. doi:10.1007/s11910-008-0053-7. PMC 2587091. PMID 18590620.
  4. Patel, Ryan; Dickenson, Anthony H. (2016-04-01). "Mechanisms of the gabapentinoids andα2δ-1 calcium channel subunit in neuropathic pain". Pharmacology Research & Perspectives. 4 (2). doi:10.1002/prp2.205. ISSN 2052-1707.
  5. Patel, Ryan; Bauer, Claudia S.; Nieto-Rostro, Manuela; Margas, Wojciech; Ferron, Laurent; Chaggar, Kanchan; Crews, Kasumi; Ramirez, Juan D.; Bennett, David L. H. (2013-10-16). "α2δ-1 Gene Deletion Affects Somatosensory Neuron Function and Delays Mechanical Hypersensitivity in Response to Peripheral Nerve Damage". Journal of Neuroscience. 33 (42): 16412–16426. doi:10.1523/jneurosci.1026-13.2013. PMC 3797367.

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.